Universal Beteiligungs und Servicegesellschaft mbH Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 19,208 shares of the medical instruments supplier’s stock, valued at approximately $287,000.

Several other large investors have also bought and sold shares of the business. Price T Rowe Associates Inc. MD grew its holdings in DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the period. Fuller & Thaler Asset Management Inc. grew its stake in shares of DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock worth $219,018,000 after purchasing an additional 314,343 shares during the period. Lazard Asset Management LLC increased its holdings in DENTSPLY SIRONA by 23.0% in the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier’s stock valued at $152,678,000 after purchasing an additional 1,505,928 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 21.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier’s stock valued at $130,045,000 after buying an additional 1,230,944 shares during the period. Finally, Geode Capital Management LLC lifted its stake in DENTSPLY SIRONA by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 3,612,370 shares of the medical instruments supplier’s stock valued at $68,584,000 after buying an additional 64,542 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Up 0.1%

XRAY stock opened at $14.31 on Tuesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.48. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. The business has a 50-day moving average of $15.93 and a 200-day moving average of $16.03. The stock has a market capitalization of $2.85 billion, a P/E ratio of -3.15, a P/E/G ratio of 1.02 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company’s quarterly revenue was down 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.42 EPS. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 4.5%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.10%.

Analyst Ratings Changes

XRAY has been the subject of a number of recent analyst reports. Piper Sandler lowered their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, April 30th. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, May 9th. Morgan Stanley cut shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target on the stock. in a research report on Tuesday, April 15th. Wall Street Zen raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Sunday, July 13th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $21.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, July 22nd. Ten research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $19.60.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.